Back
Gentera SAB de CV Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
52
CMPRF
Gentera SAB de CV
Last Price:
$2.33
Seasonality Move:
-0.83%
Sell
45
ZBIO
Zenas BioPharma, Inc.
Last Price:
$35.97
Seasonality Move:
-8.13%
Buy
52
Gentera SAB de CV (CMPRF)
is a Buy
Is Gentera SAB de CV a Buy, Sell or Hold?
-
The current Gentera SAB de CV [CMPRF] share price is $2.33. The Score for CMPRF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CMPRF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $36.89. The Score for ZBIO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CMPRF Stock Price Chart
What is Gentera SAB de CV's stock price today?
-
The Gentera SAB de CV share price today is $2.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMPRF is experiencing slight buying pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $36.89The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CMPRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 23.62 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.23 - 2.55) | Sell |
| Bollinger Bands (100): | (2.07 - 2.65) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.97 | Buy |
| Relative Strength Index (14 RSI): | 51.69 | Buy |
| Chaikin Money Flow: | 321584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CMPRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.32 | Buy |
| 20-day SMA: | 2.32 | Buy |
| 50-day SMA: | 2.53 | Sell |
| 200-day SMA: | 2.02 | Buy |
| 8-day EMA: | 2.32 | Buy |
| 20-day EMA: | 2.36 | Sell |
| 50-day EMA: | 2.4 | Sell |
| 200-day EMA: | 1.6 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.29 | Sell |
| 20-day SMA: | 37.71 | Sell |
| 50-day SMA: | 32.54 | Buy |
| 200-day SMA: | 17.6 | Buy |
| 8-day EMA: | 37.45 | Sell |
| 20-day EMA: | 34.56 | Buy |
| 50-day EMA: | 23.69 | Buy |
| 200-day EMA: | 8.26 | Buy |
Gentera SAB de CV Earnings Growth & CMPRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Gentera SAB de CV Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||